Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen - Summary of Product Characteristics
Headline percentages mean nothing if the formulation chemistry has not preserved the active peptide through the supply chain 1

You should contact your GP if: Cravings are intense and persistent , significantly interfering with your daily life or causing distress You find yourself binge eating or losing control around sugary foods, which may indicate an underlying eating disorder requiring specialist support (your GP can refer you to appropriate services, or you can contact Beat, the UK eating disorders charity) Cravings are accompanied by other symptoms such as shakiness, sweating, confusion, or palpitations, which could suggest hypoglycaemia (low blood sugar), particularly if you have diabetes You're not losing weight as expected despite adhering to Wegovy treatment, as this may indicate that cravings are leading to excessive calorie intake that counteracts the medication's effects You experience mood changes such as depression, anxiety, or irritability alongside cravings, as these may require separate assessment and management You have a history of eating disorders , as Wegovy treatment may require additional psychological support in such cases Seek urgent medical attention if you experience: Severe, persistent upper abdominal pain with or without vomiting, which could indicate pancreatitis or gallbladder disease (known risks with semaglutide) [1] [2] Persistent vomiting leading to inability to keep fluids down, which may cause dehydration Your GP can assess whether your cravings might be related to factors such as inadequate nutrition, blood sugar imbalances, medication interactions, or psychological issues

Clinical trials show that tirzepatide produces greater reductions in HbA1c and body weight than the best available GLP-1 receptor agonists
Gene expression studies consistently show that GHK-Cu shifts genetic activity from diseased or aged patterns toward healthier configurations